| Literature DB >> 27906094 |
Mathieu Bergeron1, Pierre Gauthier2, Nathalie Audet3.
Abstract
BACKGROUND: The conventional technique for cancer resection margin analysis studies only 0.1% of the surgical margins. Complete frozen section margins - also known as Mohs margins - allows for analysis of 100% of the surgical margins.Entities:
Keywords: Cancer; Frozen margins; Margins; Mohs; Oral cavity; Pathology; Recurrence; Revision; Squamous cell carcinoma; Tongue
Mesh:
Year: 2016 PMID: 27906094 PMCID: PMC5134294 DOI: 10.1186/s40463-016-0176-9
Source DB: PubMed Journal: J Otolaryngol Head Neck Surg ISSN: 1916-0208
Fig. 1Total Mohs vs Conventional margins. a demonstrates conventional margins (vertically taken), which can miss positive margin. b demonstrates Mohs technique in the margin specimen which will analyse 100% of the margins (horizontal slices)
Fig. 2Steps from molds conception to case series. a (step 1): mold conception. Molds adapted for H&N reality. Flatten the specimen with more efficiency. b (step 2): animal experience. Good quality with sharp dissection. Isopentane and cryostat offer good results. c (step 3): case series. Clear margins in oriented specimen. No short-term recurrence (n =12)
Fig. 3Surgical specimen from resection. Intraoperative Mohs margins. Image (a) demonstrates the surgical specimen about to be resected with proper orientation in both patient and the specimen. Images (b and c) demonstrate the resected specimen with corresponding sutures. Image (d) demonstrates closing time at the end of the operation once all margins were negative
Fig. 4Flow chart of inclusion criteria
General patients demographic data
| Characteristics | Conventional | Mohs |
|
|---|---|---|---|
| Number of patients | 57 | 60 | |
| Age (years) | 60.26 | 60.68 | 0.8593 |
| Male:Female | 2.2:1 | 1.6:1 | 0.444 |
| Comorbidities (%) | 0.837b | ||
| None | 24.6 | 19.2 | |
| Metabolic | 28.1 | 32.7 | |
| Cardio-vascular | 38.6 | 36.5 | |
| Respiratory | 3.5 | 7.7 | |
| Miscellaneous | 5.3 | 3.8 | |
| Flap(s) performed (%) | 71.9 | 60.0 | 0.174a |
| Subtypes | |||
| Radial forearm | 74.4 | 88.2 | |
| Anterolateral thigh | 2.3 | 2.9 | |
| Pectoralis major | 4.7 | 2.9 | |
| Fibula osteocutaneous | 11.6 | 2.9 | |
| Other | 2.3 | 2.9 | |
| Complication rate (%) | 50.9 | 42.2 | 0.488a |
| Types of complications (%) | 0.761b | ||
| Metabolic | 17.2 | 13.0 | |
| Cardio-respiratory | 17.2 | 26.1 | |
| Infectious | 24.1 | 13.0 | |
| Flap problems | 37.9 | 39.1 | |
| Miscellaneous | 3.4 | 8.7 | |
| Neck dissection (%) | 80.7 | 76.7 | 0.595a |
| Tracheotomy performed (%) | 40.43 | 35.8 | 0.627a |
| Feeding tube (%) | 73.0 | 67.3 | 0.567a |
| Feeding tube duration (days) | 14.46 | 10.89 | 0.0862c |
| ASA Class (%) | 0.714a | ||
| 1 | 14.0 | 19.2 | |
| 2 | 56.1 | 55.8 | |
| 3 | 29.8 | 25.0 | |
| Surgery duration for all patients (minutes) | 475.1 | 380.1 | 0.025c |
| Surgery duration when no flap performed (minutes) |
|
| 0.533c |
| Surgery duration for patients with flap |
|
| 0.010c |
aChi-square
bFisher cStudent t test
Fig. 5Kaplan Meier plot for cancer recurrence
Surgical and cancer characteristics
| Characteristics | Conventional | Mohs |
|
|---|---|---|---|
| Cancer Stage (%) | 0.216a | ||
| 0 | 5.3 | 3.3 | |
| I | 19.3 | 25.0 | |
| II | 15.8 | 26.7 | |
| III | 31.6 | 15.0 | |
| IV | 28.1 | 30.0 | |
| Infiltrative (%) | 75.4 | 84.6 | 0.2332b |
| Number of margins taken after primary resection (%) | <0.0001a | ||
| 0 margin | 87.7 | 31.7 | |
| 1 margin | 8.8 | 60.0 | |
| 2 margins | 3.5 | 5.0 | |
| 3 margins | 0 | 3.3 | |
| Location of positive margins (%) | 0.0861b | ||
| Floor of mouth | 42.9 | 24.3 | |
| Tongue base | 28.65 | 5.4 | |
| Deep margin | 14.3 | 48.6 | |
| Other | 14.3 | 21.6 | |
| Margins > 2 mm (%) | 83.6 | 91.7 | 0.1883b |
| Closest margins dimension (mm) | 3.949 | 2.785 | 0.0003b |
| Mild dysplasia close to margin (%) | 31.6 | 15.4 | 0.0475b |
| Perineural or perivascular invasion (%) | 21.1 | 29.6 | 0.2984b |
| Positive nodes dissection (%) | 40.0 | 43.2 | 0.7547b |
| Zones for positive nodes (%) | 0.8860a | ||
| I | 20.0 | 15.4 | |
| II | 33.3 | 46.2 | |
| III and further | 46.7 | 38.5 | |
| Capsular spreading (%) | 15.8 (3/19) | 35.3 (6/17) | 0.2553a |
| Radiation therapy (%) | 54.4 | 35.6 | 0.04191b |
| Radiation +/− Chemotherapy (%) | 57.9 | 47.5 | 0.2604b |
| Time for cancer recurrence (median, days, IQR) | 390.2 | 182.5 | 0.0832b |
| Follow-up time (median, days IQR) | 2162 | 1093 | 0.0100b |
| Cancer recurrence according to initial stages (% of recurrence) | |||
| I | 31.25 | 25 | 0.0913a |
| II | 0 | 12.5 | |
| III | 67.50 | 25 | |
| IV | 31.25 | 37.5 | |
aFicher exact test
bChi-square test